[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590277":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":33,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":37,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":53,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Medical University Innsbruck","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Thomas Sonnweber, MD, PhD","CONTACT","+43(0)51250482586","Thomas.Sonnweber@i-med.ac.at",{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},"David Haschka, MD, PhD","david.haschka@i-med.ac.at",[18],{"facility":5,"status":19,"city":20,"state":21,"zip":22,"country":21,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"RECRUITING","Innsbruck","Austria","6020","AT",{"type":25,"coordinates":26},"Point",[27,28],11.39454,47.26266,{"lat":28,"lon":27},[31],{"name":10,"role":11,"phone":32,"phoneExt":7,"email":13},"+43(0)501250482586",{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100590277","study-on-the-detection-of-pleuropulmonary-manifestations-in-rheumatoid-arthritis-100590277",false,"NCT06965322","Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis","Prospective Observational Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis","REASSESS","Inclusion Criteria:\n\n* Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR\u002FEULAR criteria\n* Residence in Austria\n* Signed and dated consent of the patient in accordance with ICH-GCP guidelines\n\nExclusion Criteria:\n\n* pregnancy\n* age below 18 years\n* Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)","ALL","18 Years",{"count":46,"type":47},800,"ESTIMATED","OBSERVATIONAL","The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).",[51,52],"Rheumatic Arthritis","Interstitial Lung Disease in Patients With Rheumatoid Arthritis",[54,55,56,57],"rheumatoid arthritis","interstitial lung disease","risk prediction","RA-ILD","2025-12-01",{"date":60,"type":61},"2025-12-02","ACTUAL",{"date":63,"type":61},"2024-11-11",{"date":65,"type":47},"2029-09-30",{"name":5,"class":6},1]